Smilow Cancer Hospital at Saint Francis

Hartford, Connecticut 06105

3 studies enrolling now · 3 studies all time

What they study most

Breast Cancer, HER2-positive Metastatic Breast Cancer, Metastatic Breast Cancer

Studies at this site

• QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer — Recruiting now
• The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study — Recruiting now
• A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment. — Recruiting now